Thyron Pharmaceuticals, Inc. — Form D
Thyron Pharmaceuticals, Inc. of WESTPORT, CT, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-03. The offering totals $1.0M, of which $500K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-05-03
- Form: D
- Accession: 0001925824-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $500K
- Remaining: $500K
- Investors: 1
- Date of first sale: 2022-04-20
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-444202
Issuer
- Name: Thyron Pharmaceuticals, Inc.
- CIK: 0001925824
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 4 DEEPWOOD LANE, WESTPORT, CT, 06880
- Phone: (203) 482-3123
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Stephen Bloch | Director | Parsippany, NJ |
| Peter Farina | Director | Durham, NC |
| Paul Fonteyne | Director | New Haven, CT |
| David Scheer | Director | Foster City, CA |
| Stephen Bloch | Executive Officer | Parsippany, NJ |
| Paul Fonteyne | Executive Officer | New Haven, CT |
| David Scheer | Executive Officer | Foster City, CA |
More